Engineered Drug Coatings Expanding the Therapeutic Envelope for Treating Chronic Diseases
Greystone Research Associates Analyzes Coating Platforms, Therapeutic Targets, Market Drivers and the Competitive Landscape
Currently more than two dozen companies are pursuing specialty coatings capable of delivering a range of drugs for treating refractory conditions. These participants are exploring a number of new and innovative approaches that include novel substrate geometries designed for the dual purpose of device integrity and drug delivery. Development efforts include new classes of drugs and novel coating application technologies and strategies.
We expect this trend to continue as competitors attempt to broaden their portfolio of technology offerings to accommodate the application needs of highly specific and evolving therapeutic protocols. In this environment, strategic relationships between and among drug, device and coating companies will continue to be an essential element of success.
These findings are contained in a new report, Engineered Drug Coatings and Coated Device Drug Delivery to 2018: Evolving Technology, Emerging Opportunities, written and researched by Greystone Research Associates. The report is designed to provide readers with a detailed understanding of enabling technologies, candidate devices, market participants and commercial prospects.
More information is available at www.greystoneassociates.org
Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
Press releases you might also be interested in
Weitere Informationen zum Thema "Medizintechnik":
Künstliche Intelligenz sorgt für mehr Transparenz
Eine intransparente Personalpolitik hätte durch den Einsatz von Künstlicher Intelligenz (KI) kaum noch eine Chance, meint etwa ein Drittel aller Führungskräfte. Das zeigt eine aktuelle Studie von Pegasystems.Weiterlesen